首页> 外文期刊>Journal of Microbiological Methods >Comparison of DNA extraction methods used to detect bacterial and yeast DNA from spiked whole blood by real-time PCR
【24h】

Comparison of DNA extraction methods used to detect bacterial and yeast DNA from spiked whole blood by real-time PCR

机译:DNA提取方法的比较通过实时PCR检测来自Spiked全血的细菌和酵母DNA

获取原文
获取原文并翻译 | 示例
           

摘要

Sepsis is the leading cause of death in intensive care units (ICUs) worldwide and its diagnosis remains a challenge. Blood culturing is the gold standard technique for blood stream infection (BSI) identification. Molecular tests to detect pathogens in whole blood enable early use of antimicrobials and affect clinical outcomes. Here, using real-time PCR, we evaluated DNA extraction using seven manual and three automated commercially available systems with whole blood samples artificially contaminated with Escherichia coli, Staphylococcus aureus, and Candida albicans, microorganisms commonly associated with BSI. Overall, the commercial kits evaluated presented several technical limitations including long turnaround time and low DNA yield and purity. The performance of the kits was comparable for detection of high microorganism loads (106 CFU/mL). However, the detection of lower concentrations was variable, despite the addition of pre-processing treatment to kits without such steps. Of the evaluated kits, the UMD-Universal CE IVD kit generated a higher quantity of DNA with greater nucleic acid purity and afforded the detection of the lowest microbial load in the samples. The inclusion of preprocessing steps with the kit seems to be critical for the detection of microorganism DNA directly from whole blood. In conclusion, future application of molecular techniques will require overcoming major challenges such as the detection of low levels of microorganism nucleic acids amidst the large quantity of human DNA present in samples or differences in the cellular structures of etiological agents that can also prevent high-quality DNA yields.
机译:败血症是全球重症监护单位(ICU)死亡的主要原因,其诊断仍然是一个挑战。血液培养是血流感染(BSI)鉴定的金标准技术。分子试验以检测全血细胞的病原体能够早期使用抗微生物和影响临床结果。在这里,使用实时PCR,我们使用七手动和三种自动商用的系统评估了DNA提取,其中包含与大肠杆菌,金黄色葡萄球菌和Candida albicans,与BSI共同相关的微生物的整体血液样本。总体而言,商业套件评估了几种技术限制,包括长周转时间和低DNA产量和纯度。试剂盒的性能对于检测高微生物载荷(106CFU / mL)。然而,尽管在没有这样的步骤的情况下,尽管在没有这样的步骤的情况下,仍然可以将较低浓度的检测是可变的。在评估的试剂盒中,UMD-Universal Ce IVD试剂盒产生较高量的具有更高核酸纯度的DNA,并得到样品中最低微生物载荷的检测。将预处理步骤包含在套件中似乎是直接从全血检测微生物DNA至关重要。总之,未来的分子技术应用需要克服的主要挑战,例如在样品中存在的大量人体DNA中检测低水平的微生物核酸,或者可以防止高质量的病因结构的细胞结构的差异DNA产量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号